Diagnos Laboratorium Utama PT Tbk (DGNS)

Jakarta
306
-10(-3.16%)
  • Volume:
    4,200,600
  • Bid/Ask:
    306/310
  • Day's Range:
    300 - 320

DGNS Overview

Prev. Close
316
Day's Range
300-320
Revenue
272.2B
Open
316
52 wk Range
266-895
EPS
41.04
Volume
4,200,600
Market Cap
395B
Dividend (Yield)
4.80
(1.56%)
Average Vol. (3m)
8,164,033
P/E Ratio
9.94
Beta
1.41
1-Year Change
-66.38%
Shares Outstanding
1,250,000,000
Next Earnings Date
-
What is your sentiment on Diagnos Laboratorium Utama PT Tbk?
or
Market is currently closed. Voting is open during market hours.

Diagnos Laboratorium Utama PT Tbk Company Profile

Diagnos Laboratorium Utama PT Tbk Company Profile

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing, preimplantation genetic testing for aneuploidy services, and preimplantation genetic testing for monogenic diseases services. It also offers homecare health services for health checks that can be done at home; corporate health services; and covid-19 check-up services, as well as health care activities managed by the government and the private sector, such as pharmacy warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other health care services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Great for long term investment
    0